If it burns in a house smoke detectors alert us hence protecting life. A molecular smoke alert has now been developed by Dresden researchers for the TP53 gene, the most important human cancer gene. The alert goes on if the TP53 gene is mutated in cells. The molecular smoke detector works like a TP53 sensor, which monitors the correct function of the gene. A non-functional TP53 gene is going to activate the sensor, which initiates cell death.
Results from this study from the research team of Prof. Frank Buchholz are now published in the journal Nature Communications.
Cancer is caused by changes in the human genome. Mutations in oncogenes and in tumor suppressor genes accumulate unrecognized over time and lead to uncontrolled cell proliferation eventually. In 50% of all human tumors the tumor suppressor gene TP53 is no longer functional being the most frequently mutated cancer gene. TU Dresden-Scientists from the University Cancer Center UCC at the University Hospital Carl Gustav Carus, the National Center for Tumor Diseases NCT Dresden and the German Cancer Consortium DKTK Dresden concluded that the formation of a TP53 sensor could suppress tumor formation at a very early stage.
To achieve this they designed a genetic element that makes cell function dependent on normal TP53. If the TP53 function is interrupted, the sensor gets activated and initiates cell death. “We treat cancer cells long after they have gone through the transformation process,” says Prof. Dr. Frank Buchholz describing the current situation. As a result, therapy is often too late to be able to eliminate all cancer cells in the body. Furthermore, due to additional mutations, therapy-resistant clones quickly emerge from some cancer cells.
“The TP53 sensor enables an active precocious intervention for the first time. Our results show that cells with TP53 mutations can be selectively detected and eliminated at an early stage. Hence, the transformation process is prevented.” The researchers plan to use their initial findings to develop new cancer diagnostics and to establish a protection system against cancer mutations in the long-term.
The Latest on: TP53 sensor
- Dr. Louis Staudt on September 13, 2018 at 5:00 pm
Dr. Louis Staudt is an internist in Philadelphia, Pennsylvania. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice for more than ... […]
- Scientists develop a sensor for the most important human cancer gene on November 13, 2017 at 4:00 pm
the most important human cancer gene. The alert goes on if the TP53 gene is mutated in cells. The molecular smoke detector works like a TP53 sensor, which monitors the correct function of the gene. A ... […]
- Competing memories of mitogen and p53 signalling control cell-cycle entry on October 4, 2017 at 12:51 pm
The number of times an article has been cited by individual mainstream news sources, blog post, or member of Google+ along with a link to the original article or post. News articles, blog posts and Go... […]
- Stress wakes up sleeping herpes viruses – but how? on February 23, 2016 at 3:59 pm
Hiding their DNA genome inside the nuclei of the infected cells, the herpes viruses establish a lifelong infection in ... stresses all lead to the activation of a set of cellular "stress sensor" prote... […]
- Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16 on February 17, 2013 at 4:00 pm
1 Molecular and Cellular Pharmacology Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA Correspondence: Professor R Anderson, Molecular and Cellular Phar... […]
- Biologists theorize role for DNA packaging in stem cell development on November 5, 2008 at 4:00 pm
MIT biologists have discovered that the organization of DNA's packing material plays a critical role in directing stem cells to become different types of adult cells. The work, to be published in the ... […]
- Double-Duty Nanoparticles Overcome Drug Resistance in Tumors on June 13, 2007 at 5:00 pm
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug resistant cancer cells that remain alive after chemotherapy are responsible for ... […]
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 on February 5, 2004 at 4:00 pm
1 Department of Discovery Oncology, Roche Research Center, Hoffmann–La Roche, Inc., Nutley, NJ 07110, USA. 2 Department of Chemistry, Roche Research Center, Hoffmann–La Roche, Inc., Nutley, NJ 07110, ... […]
via Google News and Bing News